- Philadelphia PA, US Wayne E. Childers - New Hope PA, US Marlene A. Jacobson - Melrose Park PA, US Rong Fan - Philadelphia PA, US Rogelio L. Martinez - Trenton NJ, US
Pharmaceutical compositions of the invention comprise functionalized N,N-dialkylamino phenyl ethers derivatives having a disease-modifying action in the treatment of diseases associated with lysosomal storage dysfunction that include Gaucher's disease, and any disease or condition involving lysosomal storage dysfunction.
Novel Functionalized N,N-Dialkylamino Phenyl Ethers And Their Method Of Use
- Philadelphia PA, US Wayne E. Childers - New Hope PA, US Marlene A. Jacobson - Melrose Park PA, US Magid A. Abou-Gharbia - Exton PA, US
International Classification:
C07C 225/16 C07C 49/255 A61P 31/10
Abstract:
Pharmaceutical compositions of the invention comprise functionalized N,N-dialkylamino phenyl ethers derivatives having a disease-modifying action in the treatment of diseases associated with lysosomal storage dysfunction that include Gaucher's disease, and any disease or condition involving lysosomal storage dysfunction.